Neoadjuvant radiotherapy for rectal cancer management

Table 4 Outcomes in transanal endoscopic microsurgery

Study	n	Post-op complications	Local recurrence	Survival
Lee et al[71], 2017	247	11%	7%	DFS: 80%
CARTS study, Stijns et al[68], 2019	47	N/A	7.7%	DFS: 81.6% OS: 82.8%
O’Neill et al[67], 2017	92	10.9%	6.7%	DFS: 98.6% OS: 89.4% (after 3 yr)
Jeong et al[102], 2009	45	0	15.5%	DFS: 88.5% OS: 96.2%
Stipa et al[103], 2012	86 (T1 patients)	N/A	11.6% (for T1 tumours)	OS: 92% (for T1 patients)
Baatrup et al[104],2009	143	N/A	18%	DFS: 87% OS: 66%
Van Den Eynde, 2019[105]	53	40%	N/A	N/A

DFS: Disease-free survival; OS: Overall survival.